Subcutaneous Treprostinil for Pulmonary Hypertension in Chronic Lung Disease of Infancy
Ferdman DJ, Rosenzweig EB, Zuckerman WA, Krishnan U. Subcutaneous Treprostinil for Pulmonary Hypertension in Chronic Lung Disease of Infancy. Pediatrics 2014, 134: e274-e278. PMID: 24982101, DOI: 10.1542/peds.2013-2330.Peer-Reviewed Original ResearchMeSH KeywordsAntihypertensive AgentsChronic DiseaseEpoprostenolFamilial Primary Pulmonary HypertensionFemaleHumansHypertension, PulmonaryInfantInfusions, SubcutaneousLung DiseasesMaleConceptsPulmonary arterial hypertensionChronic lung diseaseSevere pulmonary arterial hypertensionFormer premature infantsSubcutaneous treprostinilLung diseaseArterial hypertensionPulmonary hypertensionPremature infantsPersistent pulmonary arterial hypertensionIntravenous prostanoid therapySimilar hemodynamic effectsStandard respiratory careTargeted PAH therapyWeeks of therapyCatheter-related complicationsRight ventricular functionCentral venous accessSubgroup of patientsLife-threatening diseasePAH therapyProstanoid therapyConservative therapyHemodynamic effectsPreterm infants